The drug industry is having its own DeepSeek moment
It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their US ...
Hosted on MSN7h
Wall Street Analysts Thought Merck Stock Had 10% Downside Risk Heading Into Earnings. That Materialized, So What’s Next?
Merck & Co. (NYSE:MRK) is a prominent American multinational pharmaceutical company many investors know for its brand-name ...
Merck chief comm. officer Cristal Downing sells $209,550 in stock
Chief Communications and Public Affairs Officer Cristal N. Downing recently sold shares of the company, according to a filing with the Securities and Exchange Commission. On February 6, 2025, Downing ...
Two Hutchinson doctors are on a mission to save sight and change lives in Guatemala
When someone asks where you plan on traveling this year, odds are good Guatemala is not on the itinerary. But for nearly three decades, that’s exactly what two local doctors have been doing, ...
J.P. Morgan Reaffirms Their Buy Rating on Merck KGaA (0O14)
In a report released today, Richard Vosser from J.P. Morgan maintained a Buy rating on Merck KGaA (0O14 – Research Report), with a price target ...
MSD commences Phase III trial of DLBCL treatment
MSD began worldwide recruitment for the trial and subjects are currently being enrolled. In the randomised trial, the ...
RBC quantitative analyst makes eight changes to his top 40 stock picks list
RBC Capital Markets analyst Bish Koziol made eight changes to his quantitatively driven top 40 list of stock picks. Maple ...